BioWorld Asia

Jan. 31, 2007

Faith In Bio Market Pays Off With Europe's Largest Fund

LONDON - Abingworth Management closed Europe's largest ever life sciences venture fund, Abingworth Bioventures V, capping the oversubscribed fund at £300 million (US$586.9 million). (BioWorld International) Read More

GPC Biotech Banks $44M Toward Satraplatin Launch

Sleep-Inducing Drug Strategy Promises Some Sweet Dreams

Avesthagen Closes €25M Round, Proclaims Leadership In India

No Abstract Read More

Cellectis Launches IPO, Seeking €16M to €21M

No Abstract Read More

Anglo-Australian Partnership Seeks New Cancer Therapies

New Ethics Warning Issued On Nanomedicine In Europe

Plant Biotech Expert Attacks 'Dysfunctional' Regulations

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Illustration demonstrating gut-brain axis

CINP 2026: Gut microbiota could predict antidepressant response

BioWorld

The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...

Black wavy lines forming an abstract sound wave.png

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

BioWorld

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...

Ascending BCI systems deepen national security, ethical concerns

BioWorld

Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...